Pages that link to "Q26996645"
Jump to navigation
Jump to search
The following pages link to Features of protein-protein interactions that translate into potent inhibitors: topology, surface area and affinity (Q26996645):
Displayed 50 items.
- Multi-Facial, Non-Peptidic α-Helix Mimetics (Q26781261) (← links)
- Direct and Propagated Effects of Small Molecules on Protein-Protein Interaction Networks (Q26784027) (← links)
- Small Molecule Targeting of Protein-Protein Interactions through Allosteric Modulation of Dynamics (Q26785992) (← links)
- Expanding the number of 'druggable' targets: non-enzymes and protein-protein interactions (Q27003966) (← links)
- Organization, Function, and Therapeutic Targeting of the Morbillivirus RNA-Dependent RNA Polymerase Complex (Q27468732) (← links)
- Is NMR Fragment Screening Fine-Tuned to Assess Druggability of Protein–Protein Interactions? (Q27681373) (← links)
- High-Affinity Small-Molecule Inhibitors of the Menin-Mixed Lineage Leukemia (MLL) Interaction Closely Mimic a Natural Protein–Protein Interaction (Q27681486) (← links)
- Property Focused Structure-Based Optimization of Small Molecule Inhibitors of the Protein-Protein Interaction between Menin and Mixed Lineage Leukemia (MLL) (Q27703522) (← links)
- Smart surface for elution of protein-protein bound particles: nanonewton dielectrophoretic forces using atomic layer deposited oxides (Q28830310) (← links)
- Structural determinants of Tau aggregation inhibitor potency (Q30353954) (← links)
- NMR approaches in structure-based lead discovery: recent developments and new frontiers for targeting multi-protein complexes (Q30366295) (← links)
- Inhibitors of difficult protein-protein interactions identified by high-throughput screening of multiprotein complexes. (Q30546915) (← links)
- Essential multimeric enzymes in kinetoplastid parasites: A host of potentially druggable protein-protein interactions (Q33898663) (← links)
- Small-molecule inhibitors of protein-protein interactions: progressing toward the reality (Q34263719) (← links)
- Structural basis of IL-23 antagonism by an Alphabody protein scaffold (Q34445379) (← links)
- The re-emergence of natural products for drug discovery in the genomics era. (Q34459318) (← links)
- Protein engineering of the N-terminus of NEMO: structure stabilization and rescue of IKKβ binding. (Q34463911) (← links)
- Recent advances in allosteric androgen receptor inhibitors for the potential treatment of castration-resistant prostate cancer. (Q34495028) (← links)
- Development of a fluorescent monoclonal antibody-based assay to measure the allosteric effects of synthetic peptides on self-oligomerization of AGR2 protein. (Q34777828) (← links)
- Structure and mechanism of action of tau aggregation inhibitors (Q34902096) (← links)
- Development of a capillary electrophoresis platform for identifying inhibitors of protein-protein interactions (Q34995711) (← links)
- Structure-based design of small-molecule protein-protein interaction modulators: the story so far. (Q35103944) (← links)
- Challenges and opportunities in targeting the menin-MLL interaction (Q35122366) (← links)
- Protein-protein interaction modulator drug discovery: past efforts and future opportunities using a rich source of low- and high-throughput screening assays (Q35397776) (← links)
- Alternative modulation of protein-protein interactions by small molecules (Q35620999) (← links)
- A Decoy Peptide that Disrupts TIRAP Recruitment to TLRs Is Protective in a Murine Model of Influenza (Q35669847) (← links)
- Targeting protein-protein interactions in hematologic malignancies: still a challenge or a great opportunity for future therapies? (Q35687836) (← links)
- DARC 2.0: Improved Docking and Virtual Screening at Protein Interaction Sites (Q35693426) (← links)
- State-of-the-art strategies for targeting protein-protein interactions by small-molecule inhibitors (Q35738960) (← links)
- Designer macrocyclic organo-peptide hybrids inhibit the interaction between p53 and HDM2/X by accommodating a functional α-helix (Q35781290) (← links)
- Towards more drug-like proteomimetics: two-faced, synthetic α-helix mimetics based on a purine scaffold (Q35926303) (← links)
- Genome and network visualization facilitates the analyses of the effects of drugs and mutations on protein-protein and drug-protein networks (Q35951692) (← links)
- Small molecules, big targets: drug discovery faces the protein-protein interaction challenge (Q35981250) (← links)
- Rational Design of Orthogonal Multipolar Interactions with Fluorine in Protein-Ligand Complexes (Q36096683) (← links)
- Swa2, the yeast homolog of mammalian auxilin, is specifically required for the propagation of the prion variant [URE3-1]. (Q36399121) (← links)
- Structural Insights into the Tetrameric State of Aspartate-β-semialdehyde Dehydrogenases from Fungal Species (Q36574493) (← links)
- Recapitulating the α-helix: nonpeptidic, low-molecular-weight ligands for the modulation of helix-mediated protein-protein interactions (Q38164841) (← links)
- Module assembly for designing multivalent mid-sized inhibitors of protein-protein interactions (Q38168810) (← links)
- An overview of the neurobiology of suicidal behaviors as one meta-system. (Q38245264) (← links)
- The paramyxovirus polymerase complex as a target for next-generation anti-paramyxovirus therapeutics (Q38510112) (← links)
- Insights into the molecular mechanisms of action of bioportides: a strategy to target protein-protein interactions (Q38563691) (← links)
- A Computational Investigation of Small-Molecule Engagement of Hot Spots at Protein-Protein Interaction Interfaces. (Q38648131) (← links)
- Developments in SPR Fragment Screening. (Q38762947) (← links)
- Structure-guided design of small-molecule therapeutics against RSV disease (Q38798541) (← links)
- Peptidyl-Proline Isomerases (PPIases): Targets for Natural Products and Natural Product-Inspired Compounds (Q38895022) (← links)
- Validation of the Hsp70-Bag3 protein-protein interaction as a potential therapeutic target in cancer (Q38922557) (← links)
- Delineation of key XRCC4/Ligase IV interfaces for targeted disruption of non-homologous end joining DNA repair (Q39398108) (← links)
- Comprehensive experimental and computational analysis of binding energy hot spots at the NF-κB essential modulator/IKKβ protein-protein interface (Q42152060) (← links)
- Drug-Like Protein-Protein Interaction Modulators: Challenges and Opportunities for Drug Discovery and Chemical Biology (Q42701435) (← links)
- Mimicking Intermolecular Interactions of Tight Protein-Protein Complexes for Small-Molecule Antagonists. (Q47726693) (← links)